Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network (STOP-VTE)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 500
- 试验地点
- 60
- 主要终点
- Self-reported utilization of guideline concordant ePPx for surgeons (Part 1)
研究概览
简要总结
This study evaluates the use of extended venous thromboembolism prophylaxis (ePPx) following abdominopelvic cancer surgery within the NCI Community Oncology Research Program (NCORP) network, targeting surgeons and surgical advanced practice providers (APPs).
详细描述
PRIMARY OBJECTIVE:
I. To evaluate self-reported utilization of guideline concordant extended venous thromboembolism (VTE) prophylaxis (ePPx) following abdominopelvic cancer surgery within a sample of surgeons practicing within NCORP based on the Part 1 surgeon survey.
SECONDARY OBJECTIVES:
I. Evaluate site factors (e.g., proportion of publicly insured patients, proportion of Black patients, presence of a medical school, NCI designation) and surgeon factors (e.g., fellowship training, years in practice) associated with surgeon self-reported guideline concordant ePPx utilization (Part 1).
II. Conduct semi-structured interviews among a subset of surgeons and surgical APPs to assess: 1) Barriers/facilitators toward ePPx after cancer surgery and 2) Acceptability of clinical decision support tools to support VTE prophylaxis prescribing (Part 2).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •SURGEON ELIGIBILITY CRITERIA FOR OPEN STEP 0 ENROLLMENT:
- •* Any surgeon performing gastrointestinal, genitourinary, or gynecologic cancer surgery within an NCORP site, including general surgeons, surgical specialists, urologists, and gynecologists. Surgeons do not need to be involved in research or have a Cancer Therapy Evaluation Program Identification (CTEP ID) to participate in this study
- •SURGICAL APP ELIGIBILITY CRITERIA FOR OPEN STEP 0 ENROLLMENT:
- •* APPs providing postoperative care to patients operated by surgeons performing gastrointestinal, genitourinary, or gynecologic cancer surgery within an NCORP site, including general surgeons, surgical specialists, urologists, and gynecologists. Surgical APPs do not need to be involved in research or have a CTEP ID to participate in this study
- •SURGEON ELIGIBILITY CRITERIA FOR OPEN STEP 1 ENROLLMENT:
- •* Must have completed the STOP-VTE Survey - Surgeon electronically (preferred) or on paper and have it transferred to Research Electronic Data Capture (REDCap) by the contact person(s)
- •SURGICAL APP ELIGIBILITY CRITERIA FOR OPEN STEP 1 ENROLLMENT:
- •* Must have completed the STOP-VTE Survey - APP electronically (preferred) or on paper and have it transferred to REDCap by the contact person(s)
- •SITE ELIGIBILITY PART 1-SITE ENROLLMENT IN OPEN:
- •* Have at least one eligible surgeon or surgical APP who completed the STOP-VTE Survey - Surgeon/APP
排除标准
- 未提供
研究组 & 干预措施
Observational Part 1
Surgeons and APPs complete a survey on study. After completion of surgeon or APP survey, site contact person or CCDR lead complete site surveys on study.
干预措施: Non-Interventional Study (Other)
Observational Part 2
Subset of surgeons and APPs from Part 1 complete a semi-structured interview on study.
干预措施: Non-Interventional Study (Other)
Observational Part 3
Site contact person or CCDR lead complete a survey to identify a EHR Report Specialist on study. EHR Report Specialist performs an EHR Data Extraction and provides feedback on the process in a survey.
干预措施: Non-Interventional Study (Other)
结局指标
主要结局
Self-reported utilization of guideline concordant ePPx for surgeons (Part 1)
时间窗: After 1 year from start of Part 1
Will apply only to surgeons completing the Part 1 survey. Will be defined as answering "Yes, all cases or almost all cases" on the survey question asking about prescription of ePPx after discharge. The proportion of surgeons self-reporting utilization of guideline concordant ePPx will be estimated and reported along with an exact 95% confidence interval.
次要结局
- Self-reported utilization of guideline concordant ePPx for surgeons within strata defined by site and surgeon factors (Part 1)(After 1 year from start of Part 1)
- Barriers and facilitators toward ePPx after cancer surgery, and acceptability of clinical decision support tools to support VTE prophylaxis prescribing (Part 2)(After 6 months from start of Part 2)
- Feasibility (i.e., proportion of practices able to provide data) of EHR queries from selected practices to inform future trial (Part 3)(After 6 months from start of Part 3)